The clinical utility of C-peptide measurement in the care of patients with diabetes

Stability study of 81 analytes in human whole blood, in serum and in plasma

(2012) Christiane Oddoze et al.   CLINICAL BIOCHEMISTRY

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

(2012) J. Wahren et al.   DIABETES

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual  -Cell Function

(2012) J. Sherr et al.   DIABETES CARE

Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010

(2012) F. B. Barton et al.   DIABETES CARE

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

(2012) G. Thanabalasingham et al.   DIABETES CARE

The impact of insulin administration during the mixed meal tolerance test

(2012) R. E. J. Besser et al.   DIABETIC MEDICINE

Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden

(2012) Maria Thunander et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes

(2012) Tadashi Iwao et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes

(2012) Maria J. Redondo et al.   PEDIATRIC DIABETES

Mitochondrial Diabetes in Children: Seek and You Will Find It

(2012) Cristina Mazzaccara et al.   PLoS One

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature

(2012) Timothy J. McDonald et al.   PLoS One

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

(2012) Angus G Jones et al.   BMC Endocrine Disorders

Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin

(2012) Anja Schweizer et al.   Diabetes Therapy

The impact of gender on urine C-peptide creatinine ratio interpretation

(2012) N. J. Thomas et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

(2011) D. B. Sacks et al.   CLINICAL CHEMISTRY

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1- /Hepatocyte Nuclear Factor 4-  Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes

(2011) R. E. J. Besser et al.   DIABETES CARE

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes

(2011) R. E. J. Besser et al.   DIABETES CARE

Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes

(2011) P. Bowman et al.   DIABETIC MEDICINE

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes

(2011) A. G. Jones et al.   DIABETIC MEDICINE

Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes

(2011) Yoshifumi Saisho et al.   ENDOCRINE JOURNAL

C-peptide Predicts the Remission of Type 2 Diabetes After Bariatric Surgery

(2011) Wei-Jei Lee et al.   OBESITY SURGERY

C-peptide in the classification of diabetes in children and adolescents

(2011) J Ludvigsson et al.   PEDIATRIC DIABETES

Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

(2011) Soon Ae Kim et al.   Diabetes & Metabolism Journal

Autoimmune Markers in Diabetes

(2010) W. E. Winter et al.   CLINICAL CHEMISTRY

Contribution of glimepiride to basal–prandial insulin therapy in patients with type 2 diabetes

(2010) Hiroki Yokoyama et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Body Mass Index, Fasting Plasma Glucose Levels, and C-peptide Levels as Predictors of the Future Insulin Use in Japanese Type 2 Diabetic Patients

(2010) Atsushi GOTO et al.   ENDOCRINE JOURNAL

Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide

(2009) T. J. McDonald et al.   CLINICAL CHEMISTRY

Functional Assessment of Pancreatic  -Cell Area in Humans

(2009) J. J. Meier et al.   DIABETES

Glycemic Variability Correlates Strongly With Postprandial -Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents

(2009) K.-D. Kohnert et al.   DIABETES CARE

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human trials and a look into the future

(2009) M. Rewers et al.   DIABETES CARE

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study

(2009) C. Hohberg et al.   DIABETES OBESITY & METABOLISM

A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients

(2009) M. Shepherd et al.   DIABETIC MEDICINE

Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus

(2009) T. Inukai et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Measuring and estimating insulin resistance in clinical and research settings

(2009) M. Matsuda   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Phases of diabetes in children and adolescents

(2009) Jennifer Couper et al.   PEDIATRIC DIABETES

Standardization of C-Peptide Measurements

(2008) R. R. Little et al.   CLINICAL CHEMISTRY

 -Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes: Comparison of Surrogate Markers With First-Phase Insulin Secretion From an Intravenous Glucose Tolerance Test

(2008) A. Festa et al.   DIABETES

Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients

(2008) F. Panero et al.   DIABETES CARE

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of  -Cell Function in Therapeutic Trials in Type 1 Diabetes

(2008) C. J. Greenbaum et al.   DIABETES CARE

Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: Comparison with five types of high-flux dialyzer membranes

(2008) Masanori Abe et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation

(2008) R. Murphy et al.   DIABETIC MEDICINE

History and Diagnostic Significance of C-Peptide

(2008) Dietrich Brandenburg   Experimental Diabetes Research

Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline

(2008) Philip E. Cryer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

(2008) Rinki Murphy et al.   Nature clinical practice. Endocrinology & metabolism